Baclofen Efficacy and Safety Trials - Pediatric Pharmacokinetic and Pharmacodynamic Study of Oral Baclofen for the Treatment of Spasticity Associated with Cerebral Palsy (BEST-PK/PD)
NICHD study is to determine how fast the drug oral baclofen is cleared from the body, the correct dose, and long-term safety and efficacy for children with spasticity.
Information on research and on going clinic trial being sponsored by Eunice Kennedy Shriver National Institute of Child Halth and Human Development (NICHD) to determine safety, doseage and efficacy in the use of Oral Baclofen with children with cerebral palsy